858141C

17:1 Lyso PS

1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-[phospho-L-serine] (sodium salt), chloroform

• Synonym(e): 110724
• Empirische Formel (Hill-System): C₂₃H₄₃NNaO₉P
• CAS-Nummer: 1246298-15-6
• Molekulargewicht: 531.55
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: 99% (LPS; may contain up to 15% of the 2-LPS isomer, TLC)
• Form: liquid
• Verpackung: pkg of 1 × 1 mL (858141C-5mg); pkg of 1 × 4 mL (858141C-100mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 858141C
• Konzentration: 25 mg/mL (858141C-100mg); 5 mg/mL (858141C-5mg)
• Lipid-Typ: phospholipids; cardiolipins
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: O[C@](COP([O-])(OC[C@](C([O-])=O)([H])[NH3+])=O)([H])COC(CCCCCCCC/C=C\CCCCCC)=O.[Na+]

Beschreibung

Anwendung

17:1 Lyso PS may be used as a standard in graphitized carbon black-solid phase extraction (GCB-SPE) method for lipid extraction. It may also be used as an internal standard in the metabolomic analysis of cell and brain samples.

Biochem./physiol. Wirkung

17:1 Lyso PS may serve as an odd-chained LIPIDOMIX^™quantitative mass spectrometry internal standard.

Verpackung

5 mL Clear Glass Sealed Ampule (858141C-100mg)

5 mL Clear Glass Sealed Ampule (858141C-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

LIPIDOMIX is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P202 - P301 + P312 - P302 + P352 - P304 + P340 + P311 - P305 + P351 + P338 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
• Zielorgane: Liver,Kidney, Respiratory system
• Lagerklassenschlüssel: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): does not flash
• Flammpunkt (°C): does not flash